SPRiNG: SCIO-469 Patients With Rheumatoid Arthritis Not Receiving Methotrexate

NCT00089921 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

302

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: SCIO-469
DRUG: SCIO-469
DRUG: Placebo
DRUG: SCIO-469

Sponsor

Scios, Inc.